gvtcx

PHE - Sickle Cell Thalassaemia Lab Support (Screening) ECM_ 6428

Public Health England Published 31 Jan 2019 Contracts Finder

key details

Value£101,065
Statuscomplete
Category (CPV) 85000000
Deadline11 Jan 2019
Contract start12 Jan 2019
Contract end31 Dec 2022
Procedureopen
SME suitableYes
OCIDocds-b5fd17-73262d6e-b128-48ae-8001-e4a9ae95b198

Award

SupplierValueDateStatus
National Haemoglobinpathy Reference Laboratory £101,065 12 Jan 2019 active

description

The NHS Sickle Cell & Thalassaemia Screening Programme https://www.gov.uk/topic/population-screening-programmes/sickle-cell-thalassaemia was set up in 2001 to implement antenatal screening for sickle cell and thalassaemia and newborn screening for sickle cell disease. The national screening team in Public Health England (PHE Screening) provides expert advice and support to NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service.

This includes:

  • developing and monitoring standards
  • producing public information leaflets
  • quality assurance of local screening services
  • enabling accessible training and education

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
31 Jan 2019 Award (award) · e00f59b5-6f1d-4a80-9741-8ec8655be5d3-267122

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.